Tuesday, October 6, 2020

Life Sciences' New Tools: AI, IoT, Data & M&A

... finalised its US$ 4.4bn deal to acquire gene therapy company Spark Therapeutics, which became a wholly owned subsidiary of the Roche group.
http://dlvr.it/Rj2Y82
-

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...